OliX Pharmaceuticals (XKRX:226950) Net Change in Cash : ₩-8,099 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is OliX Pharmaceuticals Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

OliX Pharmaceuticals's Net Change in Cash for the three months ended in Dec. 2024 was ₩820 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-8,099 Mil.

OliX Pharmaceuticals Net Change in Cash Historical Data

The historical data trend for OliX Pharmaceuticals's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OliX Pharmaceuticals Net Change in Cash Chart

OliX Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

6,374.34

23,007.93

-29,406.47

7,052.50

-8,099.37

OliX Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															39.04	19,671.36	-25,563.00	-3,027.31	819.58

OliX Pharmaceuticals Net Change in Cash Calculation

OliX Pharmaceuticals's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-28044.991	+	973.556	+	18541.377	+	430.685
	=	-8,099

OliX Pharmaceuticals's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -8153.685 + 3880.28 + 4663.433 + 429.548

= 820

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-8,099 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OliX Pharmaceuticals Net Change in Cash Related Terms
Thank you for viewing the detailed overview of OliX Pharmaceuticals's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

OliX Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OliX Pharmaceuticals Inc (XKRX:226950) » Definitions » Net Change in Cash

Comparable Companies

XKRX:358570 XKRX:085660 XKRX:005690 XKRX:115450 XKRX:005250 XKRX:086900 XKRX:048410 XKRX:950210 XKRX:347850 XKRX:053030 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270

Traded in Other Exchanges

N/A

Address

No. 1014 Gwanggyo Ace Tower 1, Daehak 4-ro, Yeongtong-gu, Gyeonggi, Suwon, KOR, 16226

Website

http://www.olixpharma.com

OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company's pipeline products include OLX101, OLX201, OLX301, OLX102, and others.

OliX Pharmaceuticals Headlines

No Headlines